Top 5 Most-Read Multiple Myeloma Articles of 2023
Our top multiple myeloma (MM) content this year included research suggesting many patients still face poor prognoses despite advances, a case study of unique MM presentation, and research presented at the 2022 American Society of Hematology Annual Meeting.
United States American Society Of Hematology Daratumumab Plus Improved Responses Newly Diagnosed Therapeutic Developments
Source: ajmc.com